| Primary |
| Colorectal Cancer Metastatic |
16.0% |
| Hypertension |
16.0% |
| Parkinson's Disease |
8.0% |
| Non-small Cell Lung Cancer |
6.4% |
| Type 2 Diabetes Mellitus |
6.4% |
| Acute Coronary Syndrome |
5.6% |
| Chemotherapy |
4.8% |
| Constipation |
4.8% |
| Insomnia |
4.0% |
| Medical Diet |
4.0% |
| Back Pain |
3.2% |
| Breast Cancer Female |
3.2% |
| Anxiety |
2.4% |
| Atrial Fibrillation |
2.4% |
| Dyslipidaemia |
2.4% |
| Prophylaxis |
2.4% |
| Pulmonary Tuberculosis |
2.4% |
| Thrombosis Prophylaxis |
2.4% |
| Adenocarcinoma |
1.6% |
| Anaemia |
1.6% |
|
| Bradyarrhythmia |
10.7% |
| Gastric Ulcer |
7.1% |
| Glycosylated Haemoglobin Increased |
7.1% |
| Pulmonary Embolism |
7.1% |
| Sepsis |
7.1% |
| Vasculitis |
7.1% |
| Vomiting |
7.1% |
| Anxiety |
3.6% |
| Bone Marrow Failure |
3.6% |
| Bradycardia |
3.6% |
| Cardiac Arrest |
3.6% |
| Cardiac Failure Congestive |
3.6% |
| Deafness Neurosensory |
3.6% |
| Death |
3.6% |
| Diarrhoea Haemorrhagic |
3.6% |
| Gastric Cancer |
3.6% |
| Haemoptysis |
3.6% |
| Intestinal Obstruction |
3.6% |
| Lung Neoplasm |
3.6% |
| Spinal Compression Fracture |
3.6% |
|
| Secondary |
| Prostate Cancer |
9.5% |
| Pulmonary Tuberculosis |
8.4% |
| Colorectal Cancer Metastatic |
8.1% |
| Hypertension |
7.9% |
| Product Used For Unknown Indication |
7.5% |
| Hepatitis C |
6.8% |
| Drug Use For Unknown Indication |
6.7% |
| Breast Cancer |
6.0% |
| Type 2 Diabetes Mellitus |
5.7% |
| Non-small Cell Lung Cancer Stage Iv |
4.5% |
| Acute Coronary Syndrome |
4.5% |
| Prophylaxis |
4.1% |
| Breast Cancer Metastatic |
3.5% |
| Pain |
3.3% |
| Hiv Infection |
2.6% |
| Non-small Cell Lung Cancer |
2.5% |
| Premedication |
2.4% |
| Constipation |
2.1% |
| Rheumatoid Arthritis |
2.1% |
| Nausea |
2.0% |
|
| Renal Failure Acute |
13.9% |
| Dyspnoea |
7.7% |
| Pulmonary Embolism |
6.2% |
| Bronchitis |
5.8% |
| Pneumonia |
5.8% |
| Vomiting |
4.9% |
| Death |
4.7% |
| Pleural Effusion |
4.5% |
| Syncope |
4.5% |
| Cardiac Failure Congestive |
4.3% |
| Confusional State |
4.3% |
| Febrile Neutropenia |
4.3% |
| Acute Myocardial Infarction |
3.9% |
| Metabolic Acidosis |
3.9% |
| Dehydration |
3.6% |
| Hypokalaemia |
3.6% |
| Pyrexia |
3.6% |
| Sepsis |
3.6% |
| Atrial Fibrillation |
3.4% |
| Pneumothorax |
3.4% |
|
| Concomitant |
| Type 2 Diabetes Mellitus |
13.7% |
| Accidental Exposure |
10.4% |
| Prophylaxis |
10.4% |
| Atrial Fibrillation |
9.0% |
| Hypertension |
8.7% |
| Drug Use For Unknown Indication |
8.0% |
| Diabetes Mellitus |
6.0% |
| Thrombosis Prophylaxis |
4.3% |
| Acute Coronary Syndrome |
4.0% |
| Peripheral Arterial Occlusive Disease |
4.0% |
| Product Used For Unknown Indication |
3.0% |
| Nausea |
2.7% |
| Obesity |
2.3% |
| Breast Cancer |
2.0% |
| Cataract |
2.0% |
| Diabetic Neuropathy |
2.0% |
| Prophylaxis Against Diarrhoea |
2.0% |
| Reflux Oesophagitis |
2.0% |
| Angina Pectoris |
1.7% |
| Arthritis |
1.7% |
|
| Dyspnoea |
15.5% |
| Pericardial Effusion |
10.3% |
| Hypoglycaemia |
6.9% |
| Urinary Tract Infection |
6.9% |
| Anaemia |
5.2% |
| Unresponsive To Stimuli |
5.2% |
| Weight Decreased |
5.2% |
| Bradycardia |
3.4% |
| Chest Pain |
3.4% |
| Dyspepsia |
3.4% |
| Fall |
3.4% |
| Helicobacter Gastritis |
3.4% |
| Lower Gastrointestinal Haemorrhage |
3.4% |
| Pharyngotonsillitis |
3.4% |
| Pleural Effusion |
3.4% |
| Renal Failure |
3.4% |
| Syncope |
3.4% |
| Thrombocytopenic Purpura |
3.4% |
| Upper Gastrointestinal Haemorrhage |
3.4% |
| Vomiting |
3.4% |
|
